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Developing countryAbstract Background: Drug shortage is a problem that entangles health systems. In Egypt, many
complaints arose due to drug shortage in the period following the 25th January revolution.
Physicians play a vital role in dealing with this crisis.
Objectives: Our aim was to investigate physicians’ perspective of the drug shortage problem and its
impact on the healthcare system.
Methods: A questionnaire was adopted and distributed by hand to physicians in customers’ wait-
ing areas in Medical Syndicates Union. The questionnaire covered general participant information,
drug shortage effects, physicians’ responses to the problem, the magnitude of the problem and its
development three years around the revolution.
Results: Of the 319 distributed questionnaires, 192 responses were valid with a response rate of
60%. Most of participants expressed the dire impact of drug shortage on patients’ health. Death
as a result of drug shortage was reported by 67 physicians 35% of participants. A significant dif-
ference between internal medicine specialists and surgical medicine specialists in perception of drug
related deaths was found (p-value = 0.004). A significant negative correlation between number of
years of experience and agreement to analogues therapeutic equivalency was found (Spearman’s
correlation coefficient = 0.207, P-value = 0.006). About two thirds of participants viewed drug
shortages as a cause of inter-professional conflicts. Generally, participants denoted that drug short-
age problem is worsening with time since the revolution.
Conclusion: Prospective studies are required to quantitatively estimate drug shortage related mor-
tality. Enhanced drug shortage communication by drug authorities and targeted education may
relieve inter-professional conflicts resulting from drug shortages.
 2016 Publishing services provided by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).le: +20
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Drug shortage is defined as ‘‘a change in the drug supply that
has the potential to compromise patient care” [1]. Drug short-
age is a problem that entangles health systems preventing them
from achieving their goals [2]. Not only is the patient care
compromised, but healthcare team is also perplexed under
the stress of insufficient supplies [2,3]. Drug shortage is a
worldwide problem that many governments face [4].
In Egypt, drug shortage problem received much of the
media attention when Egypt faced political instabilities since
25th January 2011. In more than one instance, this was referred
to as the drug shortage crisis [5–7]. The Egyptian Drug
Authority (EDA), the official pharmaceutical body in the
Egyptian Ministry of Health and Population, created Drug
Shortage Department (DSD) to cope with the problem [8].
Currently, the DSD publishes a monthly bulletin with drugs
in shortage with suggested analogues and alternatives [9].
Physicians -as health care team leaders- play a vital role in
dealing with drug shortage. With the assistance of pharmacists,
physicians decide on alternatives, prioritize drug use in times
of low stocks, and apply frugal drug use manoeuvers [10,11].
Cooperation between physicians and pharmacists is important
for mitigating drug shortage impact on the healthcare system.
Yet, drug shortages are reported to induce inter-professional
conflicts [12]. In Egypt, a wide scope conflict between pharma-
cists and physicians manifested by Egyptian Pharmacists’
Syndicate appeal to adopt International Non-proprietary
Name prescribing policies. Pharmacists demanded more
freedom in dispensing analogous products especially when
the prescribed drug is in shortage to ease the pressure on the
health system [13].
Improved collaboration between pharmacists and physi-
cians would improve drug shortage management and mitigate
impact on health system. Understanding physicians’ percep-
tions about drug shortage and using alternatives can help in
convergence of views. The current study aimed to explore
physicians’ perceptions about drug shortage impact and physi-
cians’ acceptability of substitution.
2. Methods
2.1. Survey tool development
This is a descriptive study where a structured self-administered
questionnaire was developed based on previously published
ones [12,14–16]. The various questionnaires were reviewed in
focused group meetings to select proper questions that fit the
purpose of the study and the Egyptian case. The used question-
naire was in English and consisted of 37 points of entry in
three pages.
The first page collects general information as participants’
demographic data, academic education, and current practice
setting. Because the drug shortage bulletin published by
DSD uses two terms regarding therapeutic substitution
‘‘alternatives and analogues”, the same terms were used in the
questionnaire with their definitions. ‘‘Alternative” was defined
as a drug product that has different active ingredient but from
the same pharmacological class as the original prescribed drug.
‘‘Analogue” was defined as a drug product that has the same
active ingredient but made by different manufacturer. Thesecond page had questions about the observed drug shortage
effects on patients’ outcome and attitudes towards alternatives
and analogous products. The last page contained questions that
would help describing the magnitude of the problem and its
development with time. In the end of the last page physicians
were asked to list the most remarkable drug shortages during
the 3 years around the 25th of January revolution.
The questionnaire was validated by four physicians using
in-depth interviews and cognitive feedback techniques. All
comments were considered. Arabic translations of some terms
were added. Then, the first ten participants were asked about
the clarity and unambiguity of the questions. No additional
amendments were required at this stage.
2.2. Questionnaire distribution and collection
Between January 2013 and January 2014, physicians were
approached in customer waiting areas for subscription/renewal
of subscription in Medical Syndicates Union. The investigator
introduced himself and clarified the purpose of the study.
Physicians who agreed to participate received the self-
administered questionnaire. Physicians were totally free to
decline participation or leave the study without any conse-
quences. Physicians who initially agreed to participate then
aborted the study were recorded as dropped out. Filled ques-
tionnaires were collected by hand on the same day.
2.3. Statistical analysis
Data analysis was done using IBM SPSS Statistics, version 20
(IBM Corp. Armonk, NY). For 1 to 5 Likert type scale ques-
tions, responses more than 3 were categorized as ‘‘agreement”,
while responses less than 3 were categorized as ‘‘disagreement”
and responses with 3 were considered neutral. A wider scale
was used from the start to avoid extreme aversion bias [17].
For categorical and ordinal data, Chi-square test was used to
determine differences in frequencies of responses [18]. For
assessing the correlations between non-parametric variables,
Spearman’s correlation coefficient was used [18].
2.4. Ethical approval
The study protocol was approved (June, 2012) by the Research
Ethics Committee for experimental and clinical studies at
Faculty of Pharmacy, Cairo University. A registration sheet
was used to record participants’ names, work setting and
contact information. Registration sheet was used to detect
duplicate filling of questionnaire and exclude participants from
outside target region, Greater Cairo. Registration sheet was
kept confidential and questionnaire responses were anony-
mous. The Research Ethics Committee waived the study from
informed consent as the data were anonymously collected and
analyzed.3. Results
3.1. Demographics of participants
The number of questionnaires distributed to physicians was
319. Questionnaires were filled and returned by 192 physicians
Table 1 Demographic characteristics of participants.
Parameter Values (N= 192)
Gender: male 145 (76%)
Age in Years: Mean (SD) 37 (11)
University:
Cairo University 74 (42)
Ain Shams University 66 (38)
Azhar University 12 (7)
Private Universities 7 (4)
Universities outside Greater Cairo 16 (9)
Latest degree:
Bsc 64 (34)
Msc 83 (43)
MD/Ph.D 26 (14)
Egyptian Professional Degree 12 (6)
International Professional Degree 5 (3)
Years of experience
Less than 2 22 (12)
3–5 43 (22)
6–10 58 (30)
10–15 29 (15)
More than 15 40 (21)
BSc, Bachelor of Science; MD, Doctor of Medicine; MSc, Master
of Science; PhD, Doctor of Philosophy; SD, standard deviation.
Continuous data are presented as average (SD). Categorical and
ordinal data are presented as frequencies (%).
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(representing about 14 % of the registered hospitals in
Greater Cairo) (Table 1). Participants were from 28 different0%
Paent suﬀered from his illness without improvement
Paent received wrong medicaon
Paent condion deteriorated
Physician decided to perform a surgical operaon
A surgical operaon was delayed or cancelled
Paent died
Health outcomes of Drug Shortage
Figure 1 Physicians’ perceptions of drug
Pharmacist contacts you to suggest substitue
You accept analogu
You accept alternativ
Analogues give the same effect as prescribed dru
Alternatives give the same ffect as prescribed dru
Analogues may cause more side effe
Alternatives may cause more side effe
Physicians' Attitudes toward Substituents
Figure 2 Physicians’ attitudes towards analogs andspecialties. Most repeated specialties were general surgeons
(11%), dentists (10%), pediatricians (9%), general practition-
ers (9%), cardiologists (7%) and anesthesiologists (5%).
Categorizing physicians to surgical vs internal medicine
specialties yielded 49% in the surgical group and 51% in the
internal medicine group. Surgical specialties included general
surgery, anesthesia, obstetrics, dentistry, otorhinolaryngology,
orthopedics, ophthalmology, and urology. Internal medicine
specialties included cardiology, nephrology, gastroenterology,
hepatology, tropical medicine, pediatrics, oncology and
radiology.
Hospitals where participants had their professional
experiences were distributed in 59 different districts in the
Greater Cairo region. Large hospitals (with more than 200
beds) were represented by 43% of the sample. Seventy-six
percent of participants worked in governmental hospitals.
One fifth of the sample reported working in more than one
institution.
3.2. Perceptions of physicians about health impacts of drug
shortages
More than half the respondents (54%) reported facing troubles
finding medications to treat patients in their last shift. Median
number of patients was 3 (inter-quartile range 2 to 6 patients).
Around two thirds reported having conflicts with a pharmacist
or a nurse as a result of drug shortage.
Agreeing that drug shortages add to patients’ suffering and
may cause condition deterioration was relatively high among
participants (Fig. 1). Participants agreed that drug shortage
may delay surgical operations more than that drug shortage
may shift treatment to surgery (P-value <0.001). Death as
an outcome of drug shortage was reported more by physician25% 50% 75% 100%
Disagreement Neutral Agreement
shortage health impacts on patients.
0% 25% 50% 75% 100%
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es
es
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gs
cts
cts
Disagreement Neutral Agreement
alternatives to prescribed drugs during shortages.
194 A.A. Abdelrahman et al.with internal medicine specialties (46%) than surgical spe-
cialties (25%) (P-value = 0.004).
3.3. Perceptions about analogs and alternatives
More than one third of participants denied being contacted by
pharmacists to suggest substitutes (Fig. 2). Participants’ atti-
tudes towards analogues were significantly more positive than
alternatives in the three aspects: acceptance in time of drug
shortage (P-value <0.001), giving the same effect as prescribed
drugs (P-value <0.001) and causing more side effects than
prescribed drugs (P-value = 0.001). A significant negative cor-
relation between number of years of experience and agreement
to analogues therapeutic equivalency was found (Spearman
correlation coefficient = 0.207, P-value = 0.006). The
number of physicians who admitted prescribing analogues
during shortage was significantly higher than those who agreed
with analogues therapeutic equivalency to the prescribed drugs
(P-value <0.001). Physicians with one or two years of
experience agreed that alternatives cause more side effects than
those with more experience (P-value = 0.022).
3.4. Perceptions about drug shortage situation in relation to
political disturbance
As respondents were asked to compare year 2010 -before the
25th January revolution-, 2011 and 2012 -after the
revolution-, there was a significant difference between the three
years (P-value <0.001). The drug shortage problem, as
perceived by majority of participants, continued to increase
year by year (Fig. 3).
Participants were asked to report most important drug
shortages during the period from 2010 to 2012. The most
frequently reported product shortages were human albumin
solution, cortigen B6 -adrenal gland extract combined with
vitamin B6, used as antiemetic-, lasix ampoule -frusemide
for IV injection-, sodium bicarbonate solution for IV injection,
adrenaline ampoules, cordarone ampoules -amiodarone for
IV injection-, intraval ampoule -thiopental for IV injection-
ephedrine ampoules, protamine sulfate and contrast media
for radiography.0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
201020112012
Pe
rc
en
ta
ge
 o
f p
ar
tic
ip
an
ts
Year
Markedly 
increased
A lile increased
No change
Decreased
Figure 3 Physicians’ perception of drug shortage problem
progression from 2010 to 2012.4. Discussion
4.1. Mitigating impact of essential drugs shortages
Health impacts of drug shortages cannot be overemphasized
[19]. In this study, great majority of participants agreed that
drug shortages led to adverse patient outcomes. Increased
suffering, deterioration of patient condition and significant
delays to surgical procedures were widely reported. Shortages
of life-saving and life-sustaining medications may lead to
deaths [20]. Compared to reports from developed countries,
higher percentage of Egyptian physicians reported drug
shortage related deaths [21,22]. The high percentage implicates
inadequate drug availability and accessibility of life saving
medications. Compared to physicians with surgical medicine
specialties, physicians with internal medicine specialties were
more likely to report witnessing drug shortage related mortal-
ity. Physicians of internal medicine specialties deal more with
patients of terminal illness where life-saving and life sustaining
drugs are mostly used.
In order to decrease the adverse health outcomes of short-
age of critical drug products, the Egyptian DSD has adopted a
‘‘high priority” list of the most crucial drug products in the
Egyptian Essential Drug List. The ‘‘high priority” list includes
99 different drug formulations. ‘‘High priority” drug products
receive special attention regarding monitoring availability of
stocks at wholesalers and hospitals. Whenever stocks start to
decline without replenishment, investigations start to identify
the causes and to take appropriate actions, like expediting
batch reviews or expediting importation permissions through
the EDA. Despite efforts done by DSD, many shortages of
life-saving and life-sustaining drugs reached patient level and
may have resulted in deaths.
4.2. Insights into drug shortage management
Currently in Egypt, drug shortage management in hospitals is
a task assigned to Pharmacy and Therapeutics committees
which have monthly meetings [23]. Drug shortage is a multidi-
mensional problem. Thus, published guidelines indicate that
healthcare professionals should develop proactive coping
strategies collaboratively [11,24,25]. Both pharmacists and
physicians are required to collaborate in finding suitable
substitutes and allocating the scarce amount remaining to
the patients with the highest need [25,26]. Yet, drug shortage
is a source of inter-professional conflicts according to this
study results as well as previous reports by the Institute of Safe
Medication Practices (ISMP) [12]. Because conflicts may
impede collaborative relationships between healthcare profes-
sionals, conflicts resolution is crucial to attain best outcome
of drug shortage management [27].
Physicians’ perceptions regarding therapeutic equivalency
between analogues and prescribed drugs were unexpectedly
negative. Other studies from Malaysia, USA, Poland and
Ireland showed that physicians are more likely to have nega-
tive perceptions of generic drugs [28–31]. Physicians’ negative
impressions of generic drug products can be attributed to
physicians’ decreased awareness of generic drugs registration
processes and bioequivalence studies [28]. The negative
perceptions were correlated to physician’s years of practical
experience. Shrank et al. interpreted such correlation between
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result of changing attitudes with newer generations of physi-
cians [31]. In contrast, we attribute this negative correlation
to attitudes acquired during practicing medicine in Egypt
because of two reasons. First, new graduates are with very lit-
tle practical experience because of paucity of undergraduate
practical training. The gradual increase in negative perceptions
with an increase in experience may reflect the increase in
awareness. In developing countries, concerns regarding generic
bioequivalence have been raised in the past decade [32]. Sec-
ond, generic pharmaceutical marketing influences physicians’
decisions [33]. Older physicians are more potential prescribers
seeing higher number of patients per day. Hence, we expect
that young physicians are less approached by medical repre-
sentatives and less influenced.
In Egypt, conflict of interest between pharmacists and
physicians escalated to a wide scope involving the Egyptian
Pharmacists’ Syndicate. Current pharmacy practice law pro-
hibits substituting prescription medications without permis-
sion from prescribers [34]. Complaints of pharmacists about
physicians’ refusal of generic substitutions were raised. Egyp-
tian Pharmacists Syndicate demanded to adopt International
Non-proprietary Name prescribing policies to facilitate dis-
pensing analogous products especially during prescribed drug
shortage [13]. Despite physicians’ negative impression of
generics effectiveness, most physicians accept to substitute pre-
scribed drug with available analogous products during short-
age. Then, we attribute physicians’ refusal of generic
substitution during shortages to lack of awareness of shortage
situation. According to physicians’ instructions, patients may
prefer to search for the shortage drug and delay receiving treat-
ment rather than receiving analogous product. Patients also
are reported to have negative impressions regarding generic
substitution [35].
4.3. Drug shortage communication
In January 2014, the DSD started publishing a periodical bul-
letin with the current drug shortages and suggested generic
substitutes (analogues) and/or alternative products [9]. This
bulletin helps healthcare professionals in decisions regarding
substituting drug products. However, physicians appeared to
be less aware of the bulletin. Physicians usually know about
shortages from pharmacists [12]. Only 53% of participant
physicians admitted being contacted by pharmacists about
drug shortages while we expected a higher percentage. Active
propagation of the bulletin to physicians may enhance aware-
ness and provide better information for better decision
making.
The bulletin requires some enhancements. Publication of
the bulletin delays for one month, a significant period in which
many status changes may occur to drug shortage products in
the market. Indeed, clinicians need early warnings about
potential drug shortages. For life-saving and life-sustaining
drug products, early warnings will provide enough time to
properly plan and manage the remaining amounts of the
life-saving drugs [14]. Moreover, the published bulletin
provides little or no information regarding availability of the
drug products listed in the ‘‘high priority” list. Clinicians
may benefit from a more comprehensive and timely methodof communication such as the smart phone application
provided by FDA of USA [36].
Enhancing communication channels between authorities,
manufacturers and healthcare providers will help mitigating
impact of drug shortage on the health system. Moreover, pro-
viding education and training for physicians to address their
concerns regarding generic drug products will help in conver-
gence of views with pharmacists. The reported rate of drug
shortage related mortality necessitates prospective epidemio-
logic wide scope studies to evaluate prevalence of such
preventable cause of death.
4.4. Study limitations
The present study has a number of limitations. First, only
physicians working in Greater Cairo metropolitan area were
included. Extrapolation of the results to other rural areas
may be invalid. Second, the severe political unrest that coin-
cided with the study may have increased drug shortage related
death reports. Third, most of the participants were young
physicians. Hence, attitudes of highly experienced profession-
als may be diluted by opposing attitudes of less experienced
professionals. Finally, the long period over which the study
took place may have caused emerging trends in attitudes to
interfere with the results. After all, as the results were sup-
ported by previously published surveys in other countries, we
believe that the study results still have acceptable validity.
5. Conclusion
Patients in developing countries may be suffering from adverse
outcomes of drug shortages, including deaths, to a higher
extent compared to developed countries. Results of this study
emphasize the need for enhanced drug shortage communica-
tion and inter-professional education to improve drug shortage
management. Healthcare professionals’ behaviors may con-
tribute to the suffering from drug shortages due to lack of
awareness.
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